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A simple and efficient method for preparing 11,lZleukotriene A, has been established by the stereospecific 
biomimetic route from arachidonic acid. 12S-Hydroperoxy-52,82,10E,14Z-eicosatetraenoic ac dwas syn- 
thesized using a partially purified 1Zlipoxygenase of porcine leukocytes. The methyl ester of the compound 
was then chemically converted to two labile epoxides with a conjugated triene structure. These compounds 
were identified by proton NMR and mass spectrometry to be 1 lS,12S-oxido-52,7E,9E,l4Z-eicosatetraenoic 
acid (11,12-Ieukotriene A4) and its geometric isomer. 
12-Lipoxygenase; Leukotriene; f 1,12-Leukotriene A,; 12-Hydroperoxyicosatetraenoic acid 
1. INTRODUCTION 
Leukotrienes (LTs) are a family of biologically 
active compounds involved in inflammation and in 
allergic responses [ 1,2]. These LTs are produced by 
way of a labile allylic epoxide, LTllLl (58,64 
oxido-7E,9E, 112,142-eicosatetraenoic acid), a 
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S-lipoxygenase product [3-81. The biological 
significance of 12”lipoxygenase, another lipox- 
ygenase abundant in the blood platelets 19, lo], re- 
mains unclear. Samuelsson [l,l l] proposed the 
analogous transformation of arachidonic acid into 
1Zseries LTs via 11,12-LT&. However, the 
presence, synthesis and properties of 1 1 ,lZLTAL, 
have not yet been determined. 
We designed a simple, appropriate method for 
preparing novel LTs, 11,12-LTA4 and its isomer. 
Acquisition of these compounds paves the way for 
determination of the significance of the 
12-lipoxygenase pathway. 
2. EXPERIMENTAL 
2.1. Materials 
Arachidonic acid was obtained from Nu Chek 
Prep (Ellysian). PMP was purchased from Fluka 
(Buchs) and tri~uoromethanesulfonic anhydride 
(triflic anhydride) was from Aldrich (Milwaukee). 
Iatrobeads 6RS-8060 was from Iatron (Tokyo). All 
other reagents were of analytical grade and the 
solvents were distilled just before use. 
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2.2. Preparation of f2-HPETE 
IZHPETE was prepared using a partially 
purified porcine leukocyte 12-lipoxygenase [ 121. 
Details of the procedures will be published 
elsewhere. Briefly, 10 mg arachidonic acid was in- 
cubated with 12-lipoxygenase in 0.1 M Tris-HCl 
buffer (pH 7.4) at 4°C for 20 min. After extraction 
with diethyl ether [4], the extract was purified by 
silica gel (Iatrobeads) column chromatography and 
RP HPLC (TSK ODS-120T, 7.8 x 300 mm, 
Toyosoda, Japan). About 4 mg (36% yield) 
I2-HPETE was obtained. The methyl ester of 
12-HPETE was prepared with ethereal diazome- 
thane. For structural determination by CC-MS, 
IZHPETE methyl ester was reduced to 1ZHETE 
methyl ester using triphenylphosphine, followed 
by derivatization to the trimethylsilyl ether 
derivative. GC-MS was performed using a 
Shimadzu QP-1000 (Kyoto) equipped with 2% 
OV-I coated column (3 mm x 2 m) at 230°C. The 
derivatized compound appeared with a C value of 
21.3. Characteristic ions were observed at m/z 406 
(M), 391, 375, 316, 295 (base peak), 229, 205 and 
173, such being in good agreement with those for 
12S-HETE (91 prepared from human blood 
platelets. 
2.3. Preparation of 11,12-LTA4 
11 f12-LTG4 was prepared from 12-HPETE with 
a slight modification of Corey and Barton 1131 for 
the synthesis of LTka methyl ester from 
5-HPETE. Azeotropically dried IZHPETE 
methyl ester (1 mg, 2.8 amol) was dissolved in 
30~1 dry dichloromethane and 30 ~1 freshly dis- 
tilled tetrahydrofuran under argon. PMP (2.4~1, 
5.0 equiv.) was added, and the solution cooled to 
-78’C. Triflic anhydride (1.4~1, 2.9 equiv.) was 
added to the resulting solution, and the reaction 
mixture stirred rapidly for 2 h at -78°C. The 
reaction was quenched with triethylamine (5 pl), 
and the solution allowed to warm up to - 10°C. 
Hexane-diethyl ether-triethyl~ine (50 : 50: 1, v/v) 
was added (3 ml), followed by washing three times 
with saturated brine (0.3 ml). The organic layer 
was dried with anhydrous sodium sulfate and 
evaporated in vacua. The resulting yellowish oily 
residue, dissolved in a minimum volume of diethyl 
ether, was applied on a silica gel column 
(Iatrobeads, 0.8 x 2 cm) and eluted with hexane- 
diethyl ether-triethylamine (97 : 3 : 1, v/v). Frac- 
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tions containing the desired products were combin- 
ed, and the solvent was removed in vacua to give 
crude 11,12-LT& methyl ester (0.7 mg, 76% 
yield) determined by UV spectrum analysis. Fur- 
ther purification was performed at 4°C by 
preparative SP HPLC (Nucleosil 50-5, 10 x 
300 mm) using hex~e-diethyl ether-triethylamine 
(100:0.4:0.4, v/v), as a running solvent. 
2.4. NMR and mass spectrum analyses of 
II, I2-L TA4 and its isomer 
The structures of the compounds (0.1 mg each) 
were assigned by ‘H on a JEOL JNM-GX400 FT 
NMR spectrometer (400 MHz) in CDC13 contain- 
ing 1% deuterated pyridine at O’C, and the 
chemical shifts are reported in parts per million 
(ppm) downfield from tetramethylsilane used as 
the internal standard. Mass spectra were obtained 
using 10 pg of each sample with a Hitachi M-80A 
(EI). 
3. RESULTS 
3.1. Preparafion of II, 12-L TA4 
A typical HPLC profile of the 12-lipoxygenase 
reaction is shown in fig. 1. The major product was 
identified by GC-MS to be 12-HPETE (see section 
‘2), and a small amount of IZHETE was also 
observed. Under these conditions, the yields of 
12-HPETE and IZHETE were 68.1 and 4.4%, 
respectively. 12-HPETE methyl ester was con- 
verted to epoxide LT as described in section 2, and 
the products were analyzed by SP-HPLC (TSK gel 
silica-60, 4.6 x 250 mm, Toyosoda) using hexane- 
diethyl ether-triethylamine (100 :0.4 : 0.4, v/v) at 
4°C. When detected at 280 nm, two compounds 
appeared, named P-l (major peak) and P-2 (fig.2). 
The ratio of P-l to P-2 was about 7: 3 (w/w). The 
characteristic UV spectra of these compounds 
(Amax in methanol 268, 278, 289 nm) as shown in 
fig.3 indicated conjugated triene structures. Both 
triplet spectra shifted immediately by 10 nm to the 
shorter wavelength after addition of one drop of 
1 N HCI, thereby suggesting dihydroxy acid for- 
mation from the epoxide LTs. 
3.2. identification of lI,12-LTA4 and its isomer 
The geometrical structures of these compounds 
were determined by ‘H NMR and mass spec- 
trometry. The ‘H NMR spectral data were as 
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Fig.1. HPLC of porcine 1Zlipoxygenase products. An 
aliquot of the incubation mixture obtained at 20 min, 
quenched by 2 vols acetonitrile-methanol-acetic acid 
(350: 150: 1, v/v) cont~ning internal standard (13-hy- 
droxylinoleic acid), was injected onto the RP HPLC 
column (TSK ODS-gOTM, 4.6 x 150 mm) eluted with 
acetonitrile-methanol-water-acetic a id (350 : 150: 250 : 
1, v/v, 1 ml/min): peak 1, internal standard; peak 2, 
12-HETE; peak 3, I2-HPETE. 
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Fig-Z. HPLC of 11,12-LT& methyl ester and its isomer. 
The crude sample (25 pg) was injected onto the SP- 
HPLC column (TSK gel silica-60,4.6 x 250 mm) eluted 
at 4°C with hexane-ethyl acetate-triethylamine 
(100:0.4:0.4, v/v, 1 mllmin). 
Wavelength (nm) 
Fig.3. UV spectra of samples (P-l, P-2) purified by 
HPLC in fig.2. The HPLC fractions were evaporated 
and dissolved in the same voiume of methanol. When 
HCl was added to the cuvette, the spectra immediately 
changed (dashed lines). (A) P-l, (B) P-2. 
follows. Chemical shifts (8) are expressed as ppm, 
and s, d, t, and m denote singlet, doublet, triplet, 
and multiplet, respectively. 
(P-l) 6 6.52 (lH,dd,J= 16,ll Hz; H7 or Hs), 
6.37 (lH,dd,J=15,11 Hz; Hs or H7), 6.18 
(lH,dd,J= 14,11 Hz; Hg), 6.07 (lH,t,J= 10 Hz; 
Ha), 5.4-5.6 (4H,m; H~,HIo,H~~,HI~), 3.67 (3H,s; 
Om), 3.10 (lH,dd,J=8,2 Hz; HII), 2.92 
(lH,dt,J=8,2 Hz; H12), 2.43 (lH,m; HIS), 2.34 
(2H,t; BCGMe), 2.25 (lH,m; HIP), 2.03 
(4H,m; H4,H&, 1.74 (2H,m; H3), 1.2-1.4 (6H,m; 
HI~,Hs,Hw), 0.87 (3H,t; Hzo). 
(P-2) 6 6.47 (lH,t,J= 11 Hz; I% or Hg), 6.3 
(lH,t,J= 11 Hz; Hg or H,), 6.25 (lH,t,J= 11 Hz; 
Hg), 6.01 (lH,t,J=ll Hz; H6), 5.4-5.6 (4H,m; 
Hs,HIo,HwH,s), 3.67 (3H,s;OQ&), 3.23 (lH,dd, 
J=8,2 Hz; HI,), 2.92 (lH,dt,J=5,2 Hz; H12), 
2.44 (lH,m; HIS), 2.33 (2H,t; %COzMe), 2.25 
(lH,m; HB), 2.03 (4H,m; &,Ht& 1.74 (2H,m; 
H3). 1.2-1.4 (dH,m; HI~,HIS,HI~), 0.89, 0.87 
(fH,t,t; Hzo). 
The mass spectra of P-l and P-2 were practically 
identical. Characteristic ions were observed at m/z 
332 (M), 301 (M-OCHs), 221 (M-111), 111 
(CH2-CH = CH-(CH&-CH3), and 69 (base peak). 
These results plus the UV spectra suggest hat P-l 
is 1 lS, 12S-oxido-SZ,7E,9E, 14Seicosatetraenoic 
acid methyl ester (11,12-LT& methyl ester). P-2 
was identified as one of the isomers of 1 lS,12S- 
oxido-5Z,7,9,142-eicosatetraenoic acid. The ab- 
171 
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Fig.4. Proposed structures of 11,12-LTA4 and its 
isomer. The absolute configuration of the double bonds 
at C-7 and C-9 of P-2 remains to be clarified. 
solute configuration of the double bonds at C-7 
and C-9 of P-2 was not clearly determined because 
this compound was gradually decomposed uring 
the ‘H NMR analysis. The proposed structures of 
these compounds are shown in fig.4. 
4. DISCUSSION 
The racemic mixture of 11,12-LT& methyl ester 
was chemically synthesized from undeca-2,5-diyn- 
l-01 by Corey et al. [14], and llS,12S-LTAI was 
prepared from 2-deoxy-D-ribose by Zamboni et al. 
[15]. Since these methods require expertise for 
chemical synthesis and a large quantity of the 
starting materials, 11,12-LTA4 has not been 
readily available. We designed a simple, appro- 
priate method for the stereospecific preparation of 
purified 11,12-LT& methyl ester from arachido- 
nit acid, with a good yield (about 34%, starting 
from 12-HPETE). IZHPETE was biosynthesized 
from arachidonic acid using porcine leukocyte 
12-lipoxygenase. Use of the enzyme is efficient, 
providing that the optimal ratio of the substrate 
and enzyme amount is arranged. Detailed proce- 
dures of the synthesis of 12-HPETE will be pub- 
lished elsewhere (Mitamura et al,, in preparation). 
For the preparation of ll,lZLT& from 
IZHPETE, we used the method of Corey and Bar- 
ton [ 131 which was originally described for the syn- 
thesis of LT& methyl ester from 5-HPETE. Using 
this method, we obtained two methyl esters 
of epoxy conjugated triene, P-l and P-2, and 
these esters were separated by HPLC and proved 
to be 1 IS, lZS-oxido-5Z,7E,9E, 14Z_eicosatetra- 
enoic acid (11,12-LTA4) and its geometric iso- 
mer, respectively (fig.4). Whether or not 12-HPETE 
is converted to 11,12-LT& in vivo and which 
isomer is produced are the subjects of ongoing 
investigation. From what is known of the en- 
zymatic transformations of 5-HPETE and 15- 
HPETE, 11~,12~-oxido-5Z,7~,9~,14Z-eicosatetra- 
enoic acid (P-l) may be the correct isomer of 
11,12-LTA4. In this case the L (pro-R) hydrogen at 
C-7 is assumed to be stereoselectively eliminated. 
1ZLipoxygenase activity has been detected in 
blood platelets [9,10], porcine leukocytes [ll], rab- 
bit aortic endothelial cell (161 and the brain of 
rodents [17,18]. However, the biological signifi- 
cance and enzymatic transformations of 12- 
HPETE were not determined. Although the for- 
mation of 11,12-LT& and its further transforma- 
tion into I%-series LTs are considered [ 1,l l], no 
confirmative data have so far been available. Us- 
ing a substantial amount of 11,12-LT& and its 
isomer, the elucidation of the significance of the 
12-lipoxygenase pathway is under extensive in- 
vestigation in our laboratory. 
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